Glenmark Pharmaceuticals
750 Corporate Drive
Mahwah
NJ
07430
United States
Tel: 201-684-8000
Website: https://glenmarkpharma-us.com/
115 articles about Glenmark Pharmaceuticals
-
Glenmark Pharma Enters Exclusive Agreement With Cyndea Pharma S.L. For Generic Soft-Gelatin Capsule Drug Products
7/18/2017
-
Glenmark Pharma Licenses Small Molecule Oncology Compound From APC Therapeutics To Expand Immuno-Oncology Portfolio
6/20/2017
-
Booming Glenmark Pharma Could File One NDA Each Year For 10 Years
6/9/2017
-
Glenmark Pharma To Initiate Clinical Study For GBR 1342, Second Investigational New Drug From Immuno-Oncology Portfolio
5/15/2017
-
Glenmark Pharma Initiates Clinical Investigation For GBR 310, Its Proposed Biosimilar Candidate For XOLAIR
4/25/2017
-
Glenmark Pharma Reports Positive Results From A Phase III Trial Of GSP 301, Mometasone/Olopatadine Fixed-Dose Combination Nasal Spray, In Seasonal Allergic Rhinitis
3/29/2017
-
Glenmark Pharma Receives FDA Clearance Of IND For GSP 304
3/7/2017
-
Glenmark Pharma And Evestra Announce Partnership Agreement For Generic NuvaRing
3/2/2017
-
Glenmark Pharma Receives FDA Clearance Of IND For GBR 1302-BEAT Phase I Trial
1/3/2017
-
Glenmark Pharma' Experimental GBR 1302-BEAT Demonstrates Potent Anti-Tumor Activity In Preclinical Data Presented At The ESMO Symposium On Immuno-Oncology
11/7/2016
-
Sources Reveal Glenmark Pharma, Sun Pharma, Cipla are Exploring Bids Worth $500-800 Million for Teva's Generics Products Portfolio
11/19/2015
-
Sanofi Walks Away from a $613 Million Multiple Sclerosis Pact with Glenmark Pharma
10/30/2015
-
Jaguar Animal Health Signs Crofelemer Manufacturing & Supply Agreement With Glenmark Pharmaceuticals
9/28/2015
-
Glenmark Pharmaceuticals's Bi-Specific Antibody - GBR 1302 To Enter Phase I Trials
9/15/2015
-
Glenmark Pharmaceuticals's Novel Monoclonal Antibody GBR 830 To Enter Phase 2 Clinical Studies In Atopic Dermatitis And Celiac Disease In US And Europe
9/3/2015
-
Glenmark Pharmaceuticals Selects Life Science Industry's "Gold Standard" For Enterprise Revenue Management From Model N
8/7/2015
-
Eisai Inc. And Glenmark Pharmaceuticals Reach Settlement Over Generic Version Of BANZEL (rufinamide)
4/30/2015
-
Glenmark Pharmaceuticals's Goa And Nashik Facilities Conferred The Prestigious Greentech Environment Gold Award - 2015
2/24/2015
-
Glenmark Pharmaceuticals's TRPA1 Antagonist 'GRC 17536' Shows Positive Data In A Proof Of Concept Study
9/17/2014
-
Glenmark Pharmaceuticals Enters Oncology With The Discovery And Initiation Of IND Enabling Studies Of An Innovative Bispecific Antibody
8/20/2014